Your browser doesn't support javascript.
Amantadine Treatment for People with COVID-19.
Araújo, Ramiro; Aranda-Martínez, José Dolores; Aranda-Abreu, Gonzalo Emiliano.
  • Araújo R; Hospital da Lapa, Largo da Lapa 1, Porto, Portugal.
  • Aranda-Martínez JD; Centro Médico Cordobés, Córdoba Veracruz, México.
  • Aranda-Abreu GE; Centro de Investigaciones Cerebrales, Universidad Veracruzana, Xalapa, Veracruz, México. Electronic address: garanda@uv.mx.
Arch Med Res ; 51(7): 739-740, 2020 10.
Article in English | MEDLINE | ID: covidwho-1023466
ABSTRACT
SARS-Cov-2, whose symptoms include difficulty swallowing, coughing, diarrhea, and breathing failure, has caused the loss of many lives around the world. In the absence of a vaccine or medication to help prevent or decrease the effects of the disease, we suggest that amantadine may reduce the effects of COVID-19.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Amantadine / COVID-19 Drug Treatment Topics: Vaccines Limits: Humans Language: English Journal: Arch Med Res Journal subject: Medicine Year: 2020 Document Type: Article Affiliation country: J.arcmed.2020.06.009

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Amantadine / COVID-19 Drug Treatment Topics: Vaccines Limits: Humans Language: English Journal: Arch Med Res Journal subject: Medicine Year: 2020 Document Type: Article Affiliation country: J.arcmed.2020.06.009